June 22, 2026 Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
June 22, 2026 SPARC AI Registered as AUKUS Authorised User, Opening Pathway to US and UK Defence Markets
June 22, 2026 Syntec Optics (Nasdaq: OPTX) Secures over $4M in New BioMed Orders Across Diversified Life Sciences Platforms
